en
Report
Open access
English

COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (8) - 15.11.2021

MandatorSwiss Federal Office of Public Health (FOPH)
Number of pages94
PublisherBern : Swiss School of Public Health plus (SSPH+)
Collection
  • COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report; 8
Publication date2021-11-15
First online date2021-11-15
Abstract

This report focuses on the World Health Organization's (WHO) Emergency Use Listing (EUL) of authorized vaccines as of 11 November 2021. Bharat Biotech's new vaccine COVAXIN/ BBV152 received WHO EUL authorisation on 3 November 2021 leading to seven vaccines being now authorised for emergency use: BNT162b2/COMIRNATY (Pfizer-BioNTech, USA), Spikevax/Moderna COVID-19 Vaccine/ mRNA-1273 (Moderna, USA), Vaxzevria/ChAdOx1 nCoV-19/AZD1222/Covishield (AstraZeneca/Oxford, UK, India), Janssen Covid-19 vaccine/Johnson & Johnson (Janssen, USA), Sinopharm/BBIBP-CorV (China), Sinovac/CoronaVac (China), and COVAXIN/BBV152 (Bharat Biotech, India)]. This report provides a condensed summary concerning vaccine efficacy or effectiveness, safety, protection against variants, and further important information for each vaccine in the form of a synoptic table. The data in this synoptic table were extracted from phase III clinical trials and observational studies. This report focuses on the latest data on vaccine effectiveness, breakthrough infections, booster doses, and vaccinations in children.

eng
Citation (ISO format)
RODRIGUEZ VELÁSQUEZ, Sabina et al. COVID-19 vaccines in the WHO’s Emergency Use Listing (EUL) Report (8) - 15.11.2021. 2021
Main files (1)
Report
accessLevelPublic
Identifiers
  • PID : unige:157780
134views
27downloads

Technical informations

Creation01/07/2022 3:33:00 PM
First validation01/07/2022 3:33:00 PM
Update time03/16/2023 2:18:51 AM
Status update03/16/2023 2:18:50 AM
Last indexation01/29/2024 11:15:06 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack